NA
AIM

NewEdge Advisors’s AIM ImmunoTech AIM Stock Holding History

NewEdge Advisors’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92K Buy
+5,000
New +$5.07K ﹤0.01% 3720
2024
Q4 		– Hold
0
– – – 4091
2024
Q3 		– Hold
0
– – – 4003
2024
Q2 		– Hold
0
– – – 4071
2024
Q1 		– Hold
0
– – – 4014
2023
Q4 		– Hold
0
– – – 3937
2023
Q3 		– Hold
0
– – – 3727
2023
Q2 		– Hold
0
– – – 3477

Other funds holding AIM

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

NewEdge Advisors's AIM Position: Q1 2026 in Review

NewEdge Advisors opened a new position in AIM ImmunoTech (AIM) in Q1 2026: 5,000 shares worth $2.92K. The stake represents ﹤0.01% of the portfolio and ranks #3720 among its holdings.

18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

  • NewEdge Advisors held 5,000 shares of AIM ImmunoTech worth $2.92K as of Q1 2026.
  • AIM ImmunoTech was a new NewEdge Advisors position in Q1 2026.
  • AIM ImmunoTech made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3720 holding.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.